Syphilis Treatment Drugs Market Size

  • Report ID: 3072
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Syphilis Treatment Drugs Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

The growth of the syphilis treatment drugs market can be attributed to growing number of incidences of unprotected sex, anonymous sex and intercourse under the influence of drugs. According to the United States Centers for Disease Control and Prevention (CDC), in 2019, nearly 46% of sexually active high school students did not use a condom the last time they had sex. Half of the cases of STD are reported among people aged between 15-24 years. In addition to these, growing prevalence of syphilis in developing nations is also expected to drive market growth in the near future. Furthermore, as the prevalence of sexually transmitted diseases (STDs) is increasing, the sales of treatment drugs are also evaluated to witness a major surge in the coming years, which in turn is assessed to boost the market growth.


Syphilis-Treatment-Drugs-Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Syphilis Treatment Drugs Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Increasing incidences of unprotected sex worldwide and growing occurrence of syphilis in developing nations will impel the market growth.

North America industry is predicted to hold largest revenue share by 2037, on the back of high awareness about the disease, favorable public health insurance plans and growing advancements in the healthcare sector.

The major players in the market are GlaxoSmithKline plc, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, PerkinElmer, Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos